TetraLogic Pharmaceuticals closes $6 million Series C-1 investment - MarketLine Financial Deals

TetraLogic Pharmaceuticals closes $6 million Series C-1 investment

TetraLogic Pharmaceuticals closes $6 million Series C-1 investment - MarketLine Financial Deals
TetraLogic Pharmaceuticals closes $6 million Series C-1 investment
Published May 24, 2011
2 pages — Published May 24, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

TetraLogic Pharmaceuticals, Inc. has raised a $6 million in Series C-1 investment.

  
Source:
Document ID
MA63960_110526
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "TetraLogic Pharmaceuticals closes $6 million Series C-1 investment" May 24, 2011. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/TetraLogic-Pharmaceuticals-closes-6-million-Series-C-1-investment-2052-61491>
  
APA:
MarketLine Financial Deals. (2011). TetraLogic Pharmaceuticals closes $6 million Series C-1 investment May 24, 2011. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/TetraLogic-Pharmaceuticals-closes-6-million-Series-C-1-investment-2052-61491>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.